Article first published online: 24 NOV 2008
Copyright © 2008 American Association for the Study of Liver Diseases
Volume 48, Issue 6, page 2093, December 2008
How to Cite
- Issue published online: 24 NOV 2008
- Article first published online: 24 NOV 2008
In the article “R1626 Plus Peginterferon Alfa-2a Provides Potent Suppression of Hepatitis C Virus RNA and Significant Antiviral Synergy in Combination with Ribavirin” (HEPATOLOGY 2008;48:385-397; DOI: 10.1002/hep.22357), a number of the study investigators were not listed in the acknowledgment section. These investigators are listed below:
David E. Bernstein, North Shore–Long Island Health System, Department of Gastroenterology.
Natalie Bzowej, California Pacific Medical Center, San Francisco, CA.
Stuart C. Gordon, Henry Ford Health System, Detroit, MI.
Tarek Hassanein, University of California San Diego Medical Center, San Diego, CA.
Donald Jensen, University of Chicago, Chicago, IL.
Paul Martin, Mount Sinai School of Medicine, New York, NY.
Timothy R. Morgan, VA Long Beach Healthcare System, Long Beach, CA.
Lorenzo Rossaro, University of California, Davis Medical Center.